Close Menu

In a recent Cell Reports article, a team led by investigators at the San Raffaele Institute in Milan, Italy, shows that endogenous microRNAs, like miR-511-3p, "may operate to establish thresholds for inflammatory cell activation in tumors." In its paper, team says that "miR-511-3p modulates genetic programs of tumor-associated macrophages," and identifies direct targets of the miRNA.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.